Mahmoud Zureik

Director
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance), Saint-Denis, France, France

Poster(s):

• (S) TNF-Alpha Inhibitors Biosimilar Use in France: A 207,118 Patients Longitudinal Study
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (AM) Comparison of Potentially Inappropriate Medications in Nursing Homes and The Community: A Nationwide Cross-Sectional Study in Older Persons
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (AN) Characteristics Associated with Residual Risk of COVID-19 Hospitalisation After a Complete Vaccination Schedule in 28 million People in France
  Sunday, August 28, 2022

  8:00 AM – 1:15 PM CEST

• (172) Impact of Live Attenuated Measles, Mumps and Rubella (MMR) Vaccines on The Risk of Hospitalization with COVID-19 in Children: A Cohort Study of 7 million Children in France
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (97) Impact of Risk Minimisation Measures on The Use of High-Dose Cyproterone Acetate in France
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (269) Use of Intra-Uterine Devices in France in 2019 and Continuation Use 1 Year After: A Nationwide Observational Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST